熱門資訊> 正文
Apogee Therapeutics公开募股定价3亿美元
2025-10-09 14:18
- Apogee Therapeutics (NASDAQ:APGE) priced its public offering at $41 per share, raising ~$300M in gross proceeds.
- The offering includes 6.95M common shares and 365,853 pre-funded warrants priced at $41 each.
- Pre-funded warrants are exercisable immediately.
- Offering is expected to close on October 10, 2025.
- Apogee granted underwriters a 30-day option to purchase up to 1.1M additional shares.
- Proceeds will support the company’s clinical-stage biologics pipeline targeting inflammatory and immunology markets.
- Source: Press release
More on Apogee Therapeutics
- Apogee Therapeutics announces underwritten public offering
- Seeking Alpha’s Quant Rating on Apogee Therapeutics
- Historical earnings data for Apogee Therapeutics
- Financial information for Apogee Therapeutics
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
